{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:15:18Z","timestamp":1790615718445,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","award":["LSHM22041"],"award-info":[{"award-number":["LSHM22041"]}],"id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpsychires.2026.06.013","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:52:11Z","timestamp":1781308331000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1889-7341","authenticated-orcid":false,"given":"Juliana","family":"Lima Constantino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias Stephan","family":"Freimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-8447","authenticated-orcid":false,"given":"Jens H.","family":"van Dalfsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"van der Meij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien K.E.","family":"Veraart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne Y.","family":"Smith-Apeldoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schoevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2026.06.013_bib1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.06.013_bib2","article-title":"Oral ketamine for depression, 1: pharmacologic considerations and clinical evidence","volume":"80","author":"Andrade","year":"2019","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.013_bib3","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.2147\/NDT.S339090","article-title":"Effect of sleep disturbance on efficacy of esketamine in treatment-resistant depression: findings from randomized controlled trials","volume":"17","author":"Borentain","year":"2021","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.013_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.013_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2215-0366(15)00471-X","article-title":"Cross-trial prediction of treatment outcome in depression: a machine learning approach","volume":"3","author":"Chekroud","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"10128","key":"10.1016\/j.jpsychires.2026.06.013_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jpsychires.2026.06.013_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102888","article-title":"Eradicating suicide at its roots: preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors","volume":"19","author":"De Berardis","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105796","article-title":"Shared effects of electroconvulsive shocks and ketamine on neuroplasticity: a systematic review of animal models of depression","volume":"164","author":"De Jager","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib9","first-page":"131","article-title":"An investigation of missing data methods for classification trees applied to binary response data","volume":"11","author":"Ding","year":"2010","journal-title":"J. Mach. Learn. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.013_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1192\/bjp.2018.196","article-title":"Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study","volume":"214","author":"Domany","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.013_bib11","article-title":"All models are wrong, but many are useful: learning a variable's importance by studying an entire class of prediction models simultaneously","volume":"20","author":"Fisher","year":"2019","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107918","article-title":"All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressants","volume":"220","author":"Freudenberg","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.06.013_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/da.22968","article-title":"Defining treatment-resistant depression","volume":"37","author":"Gaynes","year":"2020","journal-title":"Depress. Anxiety"},{"issue":"Pt A","key":"10.1016\/j.jpsychires.2026.06.013_bib14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jad.2021.11.004","article-title":"Real-world evidence from a European cohort study of patients with treatment resistant depression: healthcare resource utilization","volume":"298","author":"Heerlein","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jad.2021.03.073","article-title":"Real-world evidence from a European cohort study of patients with treatment resistant depression: treatment patterns and clinical outcomes","volume":"290","author":"Heerlein","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2020.11.124","article-title":"Real-world evidence from a European cohort study of patients with treatment resistant depression: baseline patient characteristics","volume":"283","author":"Heerlein","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neubiorev.2017.03.007","article-title":"Serotonin and neuroplasticity - links between molecular, functional and structural pathophysiology in depression","volume":"77","author":"Kraus","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.013_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41398-019-0460-3","article-title":"Prognosis and improved outcomes in major depression: a review","volume":"9","author":"Kraus","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.013_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116355","article-title":"Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: a systematic review","volume":"345","author":"Lima Constantino","year":"2025","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2020.03.048","article-title":"Baseline insomnia as a predictor of antidepressant efficacy to repeated intravenous ketamine for unipolar and bipolar depression: a preliminary study","volume":"271","author":"Liu","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.jpsychires.2026.06.013_bib21","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1038\/s41380-022-01652-1","article-title":"Blood-based biomarkers of antidepressant response to ketamine and esketamine: a systematic review and meta-analysis","volume":"27","author":"Medeiros","year":"2022","journal-title":"Mol. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2026.06.013_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/15622975.2023.2169349","article-title":"Oral ketamine for depression: an updated systematic review","volume":"24","author":"Meshkat","year":"2023","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib23","article-title":"Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response","author":"Murrough","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2026.06.013_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jad.2021.12.134","article-title":"Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis","volume":"302","author":"Nu\u00f1ez","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.06.013_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.64719\/pb.4376","article-title":"An update on the efficacy and tolerability of oral ketamine for major depression: a systematic review and meta-analysis","volume":"50","author":"Nu\u00f1ez","year":"2020","journal-title":"Psychopharmacol. Bull."},{"issue":"23","key":"10.1016\/j.jpsychires.2026.06.013_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313098","article-title":"Variations in BDNF and their role in the neurotrophic antidepressant mechanisms of ketamine and esketamine: a review","volume":"25","author":"Pardossi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.013_bib27","article-title":"Best practices in supervised machine learning: a tutorial for psychologists","volume":"6","author":"Pargent","year":"2023","journal-title":"Adv. Methods Pract. Psychol. Sci."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jad.2016.08.019","article-title":"The Dutch measure for quantification of treatment resistance in depression (DM-TRD): an extension of the maudsley staging method","volume":"205","author":"Peeters","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115378","article-title":"Predicting outcome with intranasal esketamine treatment: a machine-learning, three-month study in treatment-resistant depression (ESK-LEARNING)","volume":"327","author":"Pettorruso","year":"2023","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.013_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000318293","article-title":"Efficacy and effectiveness of antidepressants: current status of research","volume":"79","author":"Pigott","year":"2010","journal-title":"Psychother. Psychosom."},{"issue":"12","key":"10.1016\/j.jpsychires.2026.06.013_bib31","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1038\/s41380-022-01757-7","article-title":"International pooled patient-level meta-analysis of ketamine infusion for depression: in search of clinical moderators","volume":"27","author":"Price","year":"2022","journal-title":"Mol. Psychiatr."},{"issue":"10","key":"10.1016\/j.jpsychires.2026.06.013_bib32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1176\/appi.ps.201900625","article-title":"Cost-effectiveness of esketamine nasal spray for patients with treatment-resistant depression in the United States","volume":"71","author":"Ross","year":"2020","journal-title":"Psychiatr. Serv."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.013_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The inventory of depressive symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol. Med."},{"issue":"11","key":"10.1016\/j.jpsychires.2026.06.013_bib34","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR\u2217D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2026.06.013_bib35","article-title":"Efficacy and safety of intranasal esketamine in treatment-resistant depression in adults: a systematic review","volume":"13","author":"Sapkota","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.013_bib36","article-title":"A review of the mechanism of antagonism of N-methyl-D-aspartate receptor by ketamine in treatment-resistant depression","volume":"10","author":"Sattar","year":"2018","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.jpsychires.2026.06.013_bib37","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/s41380-024-02478-9","article-title":"Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension","volume":"29","author":"Smith-Apeldoorn","year":"2024","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.013_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12888-019-2359-1","article-title":"Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial","volume":"19","author":"Smith-Apeldoorn","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.013_bib39","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1192\/bjo.2021.1059","article-title":"Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study","volume":"8","author":"Smith-Apeldoorn","year":"2021","journal-title":"BJPsych Open"},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.013_bib40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/02698811221084055","article-title":"The antidepressant effect and safety of non-intranasal esketamine: a systematic review","volume":"36","author":"Smith-Apeldoorn","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.013_bib41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/acps.12753","article-title":"Duration of major and minor depressive episodes and associated risk indicators in a psychiatric epidemiological cohort study of the general population","volume":"136","author":"Ten Have","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.06.013_bib42","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.11m07184","article-title":"Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations","volume":"73","author":"Troxel","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.013_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15883","article-title":"Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder","volume":"9","author":"Veraart","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.013_bib44","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1038\/s41598-022-09226-5","article-title":"Predicting non-response to multimodal day clinic treatment in severely impaired depressed patients: a machine learning approach","volume":"12","author":"Vetter","year":"2022","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jpsychires.2026.06.013_bib45","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/ijnp\/pyac049","article-title":"Predicting antidepressant effects of ketamine: the role of the pregenual anterior cingulate cortex as a multimodal neuroimaging biomarker","volume":"25","author":"Weigand","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.06.013_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2023.04.015","article-title":"Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression","volume":"333","author":"Zavaliangos-Petropulu","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.jpsychires.2026.06.013_bib47","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0269881118798614","article-title":"Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression","volume":"32","author":"Zhou","year":"2018","journal-title":"J. Psychopharmacol."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626003213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626003213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:28:32Z","timestamp":1790612912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626003213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"alternative-id":["S0022395626003213"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.06.013","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}